Safety and Effectiveness of Direct Oral Anticoagulants for the Treatment of Gastrointestinal Cancer-Associated Venous Thromboembolism

BACKGROUND: Patients with gastrointestinal cancer (GICA) are at high risk for venous thromboembolism (VTE). Data from randomized clinical trials in cancer-associated VTE suggest that direct oral anticoagulants (DOACs) conferred similar or superior efficacy but a heterogeneous safety profile in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Fauzia, Song, Juhee, Rojas Hernandez, Cristhiam M, Kroll, Michael H, Escalante, Carmelita P, Toale, Katy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628557/
https://www.ncbi.nlm.nih.gov/pubmed/37310796
http://dx.doi.org/10.1093/oncolo/oyad148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628557/
https://www.ncbi.nlm.nih.gov/pubmed/37310796
http://dx.doi.org/10.1093/oncolo/oyad148

Ejemplares similares